Supplementary Table S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

20230 citationssupplementary-materialsgold Open Access

Authors

<p>Binding affinity of MW282 mAb, 9MW2821, and enfortumab vedotin based on enzyme linked immunosorbent assay</p>

Good health and well-being

Field-Weighted Citation Impact: 0.00